Association of immunoescape mechanisms with Epstein‐Barr virus infection in nasopharyngeal carcinoma
Authors:
Open Access
- 27 March 2007
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 120 (11) , 2401-2410
Abstract
We have investigated the association of immunoescape mechanisms in nasopharyngeal carcinoma (NPC) lesions with Epstein‐Barr virus (EBV) infection and clinical course of the disease. Tumor biopsy specimens obtained from 36 Japanese NPC patients were examined for antigen processing machinery component and HLA class I antigen expression, CD8+T cell infiltration, and Fas, Fas ligand (FasL) and IL‐10 expression using immunohistochemical staining. The results were correlated with the histopathological characteristics of the lesions, the clinical course of the disease and EBV infection. LMP2, TAP1, tapasin and HLA class I antigens were downregulated in more than 65% of the lesions tested, while FasL, Fas and IL‐10 were expressed in at least 60% of the lesions. Statistical analysis showed that (i) HLA class I antigen expression was significantly correlated with LMP2 and tapasin expression (r= 0.39 and 0.45, respectively); (ii) CD8+T cell infiltration into tumor lesions was significantly correlated with HLA class I antigen, LMP2 and Fas expression (r= 0.34, 0.49 and 0.44, respectively); (iii) LMP2 and FasL expression was significantly correlated with IL‐10 expression (r= 0.49 and 0.52, respectively); (iv) IL‐10 expression was significantly associated with EBERs and EBV oncoprotein LMP1 expression (p= 0.00078 and 0.015, respectively) and (v) FasL overexpression was significantly associated with reduced patients' survival (p= 0.033). Multivariate analysis identified FasL overexpression as an independent unfavorable prognostic marker. These results suggest that NPC cells may utilize multiple immunoescape mechanisms, including dysfunction of HLA class I antigens and Fas/FasL apoptosis pathways. Furthermore, FasL expression appears to be associated with IL‐10 upregulation in EBV positive NPC cells.Keywords
This publication has 38 references indexed in Scilit:
- Development and characterization of human constitutive proteasome and immunoproteasome subunit‐specific monoclonal antibodiesTissue Antigens, 2005
- Prognostic implications of Fas‐ligand expression in nasopharyngeal carcinomaHead & Neck, 2004
- IL‐12 receptor‐mediated upregulation of FasL in human ovarian carcinoma cellsInternational Journal of Cancer, 2004
- The role of Fas ligand and transforming growth factor β in tumor progressionCancer, 2004
- Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinomaThe Journal of Pathology, 2003
- Characterization of antigen processing machinery and Survivin expression in tonsillar squamous cell carcinomaCancer, 2003
- Fas and Fas ligand expression is elevated in prostatic intraepithelial neoplasia and prostatic adenocarcinomaCancer, 2002
- Fas (CD95/APO‐1) and Fas ligand expression in normal pancreas and pancreatic tumorsCancer, 2002
- β2‐μ‐free HLA class I heavy chain levels in sera of healthy individuals. Lack of association with β2‐μ‐associated HLA class I heavy chain levels and HLA phenotypeTissue Antigens, 1999
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958